Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Janssen (Leiden, Netherlands), M. Spruit (Horn, Netherlands), J. Antons (Nijmegen, Netherlands), R. Djamin (Breda, Netherlands), T. Tjalma (Breda, Netherlands), H. In ’T Veen (Rotterdam, Netherlands), S. Simons (Maastricht, Netherlands), H. Van Helvoort (Nijmegen, Netherlands), A. Van ’T Hul (Nijmegen, Netherlands). Prevalence of non-pharmacological treatable traits in patients with asthma. 941

Member's Comments

No comment yet.

Related content which might interest you: Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Prevalence of psychiatric disorders in seriously-ill COPD patients Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Prevalence of psychiatric disorders in patients undergoing specific challenge tests for the diagnosis of occupational asthma Source: Annual Congress 2008 - Occupational asthma - agents and management Year: 2008 Evaluation of the difficult-to-treat severe asthma patient in the clinic Source: Eur Respir Mon 2011; 51: 16-27 Year: 2011 How can treatable traits be used in severe exacerbations? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Prevalence and risk factors of depression in patients with COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Characterisation of patients with difficult-to-treat and treatment-resistant severe asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Risk factors of frequent exacerbations in difficult-to-treat asthma Source: Eur Respir J 2006; 27: 1324-1325 Year: 2006 Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Prevalence of comorbidities in patients with COPD in south-Spain Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Factors influencing medication adherence amongst difficult-to-treat asthma patients Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Treatable traits qualifying for nonpharmacological interventions in COPD patients upon first referral to a pulmonologist: the COPD sTRAITosphere Source: ERJ Open Res, 6 (4) 00438-2020; 10.1183/23120541.00438-2020 Year: 2020 Do COPD severity parameters predict mood disorders? Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Impact of comorbidities in difficult to treat asthma Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Systematic assessment of difficult-to-treat asthma Source: Eur Respir J 2003; 22: 478-483 Year: 2003 Risk factors responsible for the development of severe asthma in outpatients Source: Eur Respir J 2002; 20: Suppl. 38, 427s Year: 2002